Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 444 participants.

Also called NCT02201667

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 444 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02201667
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02201667. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
Condition
Acute Coronary Syndrome
Intervention (Drug)
Ticagrelor
Intervention (Drug)
clopidogrel
Intervention (Drug)
Aspirin
Lead sponsor
RenJi Hospital (class: other)

Record details

Record id
cardio:ct-nct02201667
Content hash
bd1132e10d98edc41e4973f2aa863130978ddaaf15ae453029983bb8ff072904